<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00417859</url>
  </required_header>
  <id_info>
    <org_study_id>HO 218/01</org_study_id>
    <nct_id>NCT00417859</nct_id>
  </id_info>
  <brief_title>Total Knee Arthroplasty: Comparison of Fixed and Mobile Bearings</brief_title>
  <official_title>Total Knee Arthroplasty: Comparison of Fixed and Mobile Bearings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <brief_summary>
    <textblock>
      The goal of this study is to provide gait parameters as a new objective method to assess
      total knee arthroplasty outcome between patients with fixed- and mobile-bearing, using an
      ambulatory device with minimal sensor configuration.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2004</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gait Stride Length</measure>
    <time_frame>5years</time_frame>
    <description>distance in meters of gait stride lenght measured by a data logger with five inertial sensors</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EuroQoL Quality of Life Scale (EQ-5D)</measure>
    <time_frame>5years</time_frame>
    <description>The EQ-5D is a measure of self-reported health outcomes that is applicable to a wide range of health conditions and treatments. It consists of two parts: a descriptive system (Part I) and a visual analogue scale (VAS) (Part II). Part I of the scale consists of 5 single-item dimensions including: mobility, self care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has a 3 point response scale designed to indicate the level of the problem. Part II uses a vertical graduated VAS (thermometer) to measure health status, ranging from worst imaginable health state to best imaginable health state. T.
Descriptive data from the 5 dimensions of Part I can be used to generate a health-related quality of life profile for the subject. Part II is scored from 0 (worst health state imaginable) to 100 (best health state imaginable). The score from Part II can be used to track changes in health, on an individual or group level, over time.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Semi-objective Evaluation Knee Sciety Score (KSS) Clinical Outcome Measures</measure>
    <time_frame>5years</time_frame>
    <description>Scoring system to clinically rate the knee abefore and after TK, scored from 0 to 100 with lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Dislocation</measure>
    <time_frame>5years</time_frame>
    <description>count of numbers of dislocated implants.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>TKA mobile</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TKA mobile</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TKA</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>TKA fix</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total knee arthroplasty: mobile bearing</intervention_name>
    <description>Total knee arthroplasty: mobile bearing</description>
    <arm_group_label>TKA mobile</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suffering from a primary unilateral knee osteoarthritis and requiring a knee
             replacement

          -  Informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>B Jolles, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOSR</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HOSR</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 3, 2007</study_first_submitted>
  <study_first_submitted_qc>January 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2007</study_first_posted>
  <results_first_submitted>February 27, 2020</results_first_submitted>
  <results_first_submitted_qc>April 6, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 7, 2020</results_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Brigitte Jolles, MD</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>8 patients were excluded</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>TKA Mobile</title>
          <description>TKA mobile
Total knee arthroplasty with mobile bearing implant.</description>
        </group>
        <group group_id="P2">
          <title>TKA Fix</title>
          <description>Total knee arthroplasty with fixed bearing implant.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>TKA Mobile</title>
          <description>TKA mobile
Total knee arthroplasty: mobile bearing: Total knee arthroplasty: mobile bearing</description>
        </group>
        <group group_id="B2">
          <title>TKA Fix</title>
          <description>TKA fix</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="56"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.1" spread="8.3"/>
                    <measurement group_id="B2" value="70.2" spread="7.1"/>
                    <measurement group_id="B3" value="68.7" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Gait Stride Length</title>
        <description>distance in meters of gait stride lenght measured by a data logger with five inertial sensors</description>
        <time_frame>5years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Preoperative</title>
            <description>preoperative stride lenght of all participants</description>
          </group>
          <group group_id="O2">
            <title>5 Years</title>
            <description>stride lenght at 1 year following TKA of all participants</description>
          </group>
        </group_list>
        <measure>
          <title>Gait Stride Length</title>
          <description>distance in meters of gait stride lenght measured by a data logger with five inertial sensors</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" lower_limit="1.1" upper_limit="1.3"/>
                    <measurement group_id="O2" value="1.2" lower_limit="1.1" upper_limit="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>FB group was designated the control group. We determined a sample size based in clinical criteria. Using an α of 0.05 and β of 0.8, the required sample size was calculated to be 24 patients in each group to achieve a power of 80%. Descriptive analysis was completed on demographic information and clinical and radiological outcomes. Nonparametric tests (Wilcoxon’s signed ranks or rank sum tests) were used for comparison of scores. The chi-squared test was used for dichotomous variables.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.05</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>EuroQoL Quality of Life Scale (EQ-5D)</title>
        <description>The EQ-5D is a measure of self-reported health outcomes that is applicable to a wide range of health conditions and treatments. It consists of two parts: a descriptive system (Part I) and a visual analogue scale (VAS) (Part II). Part I of the scale consists of 5 single-item dimensions including: mobility, self care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has a 3 point response scale designed to indicate the level of the problem. Part II uses a vertical graduated VAS (thermometer) to measure health status, ranging from worst imaginable health state to best imaginable health state. T.
Descriptive data from the 5 dimensions of Part I can be used to generate a health-related quality of life profile for the subject. Part II is scored from 0 (worst health state imaginable) to 100 (best health state imaginable). The score from Part II can be used to track changes in health, on an individual or group level, over time.</description>
        <time_frame>5years</time_frame>
        <population>data collected in 25 patients on each group (as this a patient reported outcome, thr data was missing in some of the cases)</population>
        <group_list>
          <group group_id="O1">
            <title>TKA Mobile</title>
            <description>TKA mobile
Total knee arthroplasty: mobile bearing: Total knee arthroplasty: mobile bearing</description>
          </group>
          <group group_id="O2">
            <title>TKA Fix</title>
            <description>TKA fix</description>
          </group>
        </group_list>
        <measure>
          <title>EuroQoL Quality of Life Scale (EQ-5D)</title>
          <description>The EQ-5D is a measure of self-reported health outcomes that is applicable to a wide range of health conditions and treatments. It consists of two parts: a descriptive system (Part I) and a visual analogue scale (VAS) (Part II). Part I of the scale consists of 5 single-item dimensions including: mobility, self care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has a 3 point response scale designed to indicate the level of the problem. Part II uses a vertical graduated VAS (thermometer) to measure health status, ranging from worst imaginable health state to best imaginable health state. T.
Descriptive data from the 5 dimensions of Part I can be used to generate a health-related quality of life profile for the subject. Part II is scored from 0 (worst health state imaginable) to 100 (best health state imaginable). The score from Part II can be used to track changes in health, on an individual or group level, over time.</description>
          <population>data collected in 25 patients on each group (as this a patient reported outcome, thr data was missing in some of the cases)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.3" spread="17.5"/>
                    <measurement group_id="O2" value="79.9" spread="18.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Semi-objective Evaluation Knee Sciety Score (KSS) Clinical Outcome Measures</title>
        <description>Scoring system to clinically rate the knee abefore and after TK, scored from 0 to 100 with lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions.</description>
        <time_frame>5years</time_frame>
        <population>data collected in 25 patients on each group (as this a patient reported outcome, thr data was missing in some of the cases)</population>
        <group_list>
          <group group_id="O1">
            <title>TKA Mobile</title>
            <description>TKA mobile
Total knee arthroplasty: mobile bearing: Total knee arthroplasty: mobile bearing</description>
          </group>
          <group group_id="O2">
            <title>TKA Fix</title>
            <description>TKA fix</description>
          </group>
        </group_list>
        <measure>
          <title>Semi-objective Evaluation Knee Sciety Score (KSS) Clinical Outcome Measures</title>
          <description>Scoring system to clinically rate the knee abefore and after TK, scored from 0 to 100 with lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions.</description>
          <population>data collected in 25 patients on each group (as this a patient reported outcome, thr data was missing in some of the cases)</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.7" spread="12.8"/>
                    <measurement group_id="O2" value="49.3" spread="19.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Dislocation</title>
        <description>count of numbers of dislocated implants.</description>
        <time_frame>5years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>TKA Mobile</title>
            <description>TKA mobile
Total knee arthroplasty: mobile bearing: Total knee arthroplasty: mobile bearing</description>
          </group>
          <group group_id="O2">
            <title>TKA Fix</title>
            <description>TKA fix</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Dislocation</title>
          <description>count of numbers of dislocated implants.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>TKA Mobile</title>
          <description>TKA mobile
Total knee arthroplasty: mobile bearing: Total knee arthroplasty: mobile bearing</description>
        </group>
        <group group_id="E2">
          <title>TKA Fix</title>
          <description>TKA fix</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>postoperative varus knee laxity due to a deficiency in the fibular collateral ligament</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof Brigitte Jolles</name_or_title>
      <organization>University Hospital of Lausanne</organization>
      <phone>0213149629</phone>
      <email>brigitte.jolles@chuv.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

